Apeiron Synthesis S.A.
About this exhibitor
Apeiron’s core technology, catalytic olefin metathesis, is revolutionizing the way chemists synthesize organic molecules. From the discovery of metathesis in the industrial laboratories of the 1950s, to the Nobel Prize awarded in 2005, an understanding of its mechanisms and potentials has increased exponentially. The promise and revolution of olefin metathesis is now being fully integrated into real world commercial applications.
Apeiron has been established in 2009 by a team of top scientists and entrepreneurs. Since this time, we have been bringing this technology to global customers in the pharma, agrochemical, flavor & fragrance, petrochemical and polymer sectors.
Building on this mission, Apeiron is now transforming metathesis into a powerful tool for the efficient and clean creation of chemical architectures for commercial applications. Our strategic solutions provide industry with the tools to benefit from the revolution.
Apeiron’s team aspires to work hand-in-hand with customers to help transform their chemistry and bring about a revolution in catalysis and synthesis for R&D pipelines and manufacturing processes. We seek to advance the frontiers of chemical transformation, creating efficient and cost-effective solutions for commercial applications.
Our product is invention and our roots run deep in science and discovery which are at the heart of our mission. Our measure of success is when we help make your manufacturing processes faster, cheaper and greener.
From the high tech labs and old-world charms of Wroclaw, Poland to our North American site at the Cambridge Innovation Center – in the heart of the world’s preeminent life-sciences/pharma cluster of Cambridge, Massachusetts – we are ready to bring the solutions and science of chemical transformation and synthesis to you.